Abstract:Different gold nanosystems covered with DNA and doxorubicin (Doxo) were designed and synthesized for cancer therapy, starting from Au@16-Ph-16 cationic nanoparticles and DNA–Doxo complexes prepared under saturation conditions. For the preparation of stable, biocompatible, and small-sized compacted Au@16-Ph-16/DNA–Doxo nanotransporters, the conditions for the DNA–Doxo compaction process induced by gold nanoparticles were first explored using fluorescence spectroscopy, circular dichroism and atomic force microscopy techniques. The reverse process, which is fundamental for Doxo liberation at the site of action, was found to occur at higher CAu@16-Ph-16 concentrations using these techniques. Zeta potential, dynamic light scattering and UV–visible spectroscopy reveal that the prepared compacted nanosystems are stable, highly charged and of adequate size for the effective delivery of Doxo to the cell. This fact is verified by in vitro biocompatibility and internalization studies using two prostate cancer-derived cell lines (LNCaP and DU145) and one hepatocellular carcinoma-derived cell line (SNU-387), as well as a non-tumor prostate (PNT2) cell line and a non-hepatocarcinoma hepatoblastoma cell line (Hep-G2) model used as a control in liver cells. However, the most outstanding results of this work are derived from the use of the CI+NI combined treatments which present strong action in cancer-derived cell lines, while a protective effect is observed in non-tumor cell lines. Hence, novel therapeutic targets based on gold nanoparticles denote high selectivity compared to conventional treatment based on free Doxo at the same concentration. The results obtained show the viability of both the proposed methodology for internalization of compacted nanocomplexes inside the cell and the effectiveness of the possible treatment and minimization of side effects in prostate and liver cancer.

DNA-caged gold nanoparticles for controlled release of doxorubicin triggered by a DNA enzyme and pH

Ribbon of DNA Lattice on Gold Nanoparticles for Selective Drug Delivery to Cancer Cells.

A self-assembled DNA nanostructure for targeted and pH-triggered drug delivery to combat doxorubicin resistance

DNA Nanocages Swallow Gold Nanoparticles (aunps) to Form AuNP@DNA Cage Core-Shell Structures.

Facile construction of targeted pH-responsive DNA-conjugated gold nanoparticles for synergistic photothermal-chemotherapy

A Ph-Responsive DNA Nanomachine-Controlled Catalytic Assembly of Gold Nanoparticles

A pH responsive micelle combined with Au nanoparticles for multi-stimuli release of both hydrophobic and hydrophilic drug

A Ph-Driven DNA Nanoswitch for Responsive Controlled Release.

Terminal Deoxynucleotidyl Transferase-Catalyzed Preparation of Ph-Responsive DNA Nanocarriers for Tumor-Targeted Drug Delivery and Therapy.

Three-Dimensional Molecular Transfer from DNA Nanocages to Inner Gold Nanoparticle Surfaces.

Hollow Polyethyleneimine Nanoparticles with Drug Loaded DNA for Chemotherapeutic Applications

Gold Nanosystems Covered with Doxorubicin/DNA Complexes: A Therapeutic Target for Prostate and Liver Cancer

Dual-responsive Drug Release from Oligonucleotide-Capped Mesoporous Silica Nanoparticles.

Ph, Redox and Photothermal Tri-Responsive DNA/polyethylenimine Conjugated Gold Nanorods As Nanocarriers for Specific Intracellular Co-Release of Doxorubicin and Chemosensitizer Pyronaridine to Combat Multidrug Resistant Cancer.

Aptamer-coded DNA Nanoparticles for Targeted Doxorubicin Delivery Using Ph-Sensitive Spacer

Remote-Controlled DNA Release from Fe3O4@Au Nanoparticles Using an Alternating Electromagnetic Field

DNA Origami/gold Nanorod Hybrid Nanostructures for the Circumvention of Drug Resistance.

Drug Delivery: Efficient, Ph‐triggered Drug Delivery Using a Ph‐responsive DNA‐Conjugated Gold Nanoparticle (adv. Healthcare Mater. 2/2013)

A cancer-targeted drug delivery system developed with gold nanoparticle mediated DNA–doxorubicin conjugates

Structure-Switchable DNA Programmed Disassembly of Nanoparticles for Smart Size Tunability and Cancer-Specific Drug Release.

Ph and Near-Infrared Light Dual-Stimuli Responsive Drug Delivery Using DNA-conjugated Gold Nanorods for Effective Treatment of Multidrug Resistant Cancer Cells.